AdvertisementOne-Third Of New Drugs Had Safety Problems After FDA ApprovalMay 09, 2017Sydney LupkinfacebookEmailThe anti-inflammatory drug Bextra was taken off the market because it increased the risk of heart attack and stroke. (Bloomberg via Getty Images)
